Affluent Medical: Financial results for H1 2022 -2-

DJ Affluent Medical: Financial results for H1 2022 and significant progresses in 2022. Affluent Medical Affluent Medical: Financial results for H1 2022 and significant progresses in 2022. 28-Sep-2022

Related Keywords

Aix En Provence ,Provence Alpes Côd Azur ,France ,United States ,Paris ,France General ,Brussels ,Bruxelles Capitale ,Belgium ,French ,Jennifer Jullia ,Astra Zeneca ,Daniel Hayoz ,Ecole Nationale ,Siemens Healthineers ,Maison Alfort ,Christophe Giot ,Geoffroy Ghislaine Gasparetto ,Edwards Lifesciences ,Michel Therin ,Clinical Affairs ,Investor Access Forum ,English Company ,Clinical Affairs Europe ,Medtronic ,News Service ,Bristol Myers Squibb ,Medical Affluent ,French Regulatory News ,Affluent Medical ,Chief Executive Officer ,Board Member ,Vice President ,French Medtech ,Michel Finance ,Boardof Directors ,Chief Executive ,Investment Portfolio Management ,New Shares ,Preferential Subscription Rights ,General Manager ,Floreane Medical Implants ,Vice President Clinical Affairs ,Chief Medical Officer ,Statutory Auditors ,Dow Jones Newswires ,Kreos Capital ,Head Leader ,Des March ,Access Forum ,Truffle Capital ,Ghislaine Gasparetto ,Chief Financial Officer ,Thomas Roborel De Climens ,Provence France ,Affluent ,Medical ,Financial ,Results ,022 ,